Carbon-14 radiolabeling and tissue distribution evaluation of MMV390048.

The antimalarial compound MMV390048 ([ C]-11) was labeled with carbon-14 isotope via a 3-step synthesis. It was obtained in a 15.5% radiochemical overall yield from carbon-14 labeled methyl iodide with a radiochemical purity of >99%.

(Z)-Ethyl 2-hy-droxy-4-oxo-4-(1,4,5,6,8-penta-meth-oxy-naphthalen-2-yl)but-2-enoate.

The title compound, C21H24O9, crystallizes with two independent mol-ecules in the asymmetric unit which are almost centrosymmetrically related to each other. The ethano-ate group in one of the two mol-ecules is disordered over two positions with a site-occupation factor of 0.880 (7) for the major occupied site.

The synthesis of the pyranonaphthoquinones dehydroherbarin and anhydrofusarubin using Wacker oxidation methodology as a key step and other unexpected oxidation reactions with ceric ammonium nitrate and salcomine.

The synthesis of two closely related pyranonaphthoquinones, dehydroherbarin and anhydrofusarubin, is described. The construction of the naphthalene nuclei was achieved using the Stobbe condensation reaction using 2,4-dimethoxybenzaldehyde and 2,4,5-trimethoxybenzaldehyde as their respective starting materials. Two key steps en route include a PIFA-mediated addition of a methoxy substituent onto the naphthalene skeleton and a Wacker oxidation reaction to construct the benzo[g]isochromene nucleus.